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Background: To establish a potential gene-delivery system with the ability to deliver plasmid 
DNA to dendritic cells (DCs) more efficiently and specifically, we designed and synthesized 
a low-molecular-weight polyethyleneimine and triethyleneglycol polymer (PEI–TEG) and a 
series of its mannosylated derivatives.
Methods: PEI–TEG was synthesized from PEI2000 and PEI600 with TEG as the cross-linker. 
PEI–TEG was then linked to mannose via a phenylisothiocyanate bridge to obtain man-PEI–
TEG conjugates. The DNA conveyance abilities of PEI–TEG, man-PEI–TEG, as well as con-
trol PEI25k were evaluated by measuring their zeta potential, particle size, and DNA-binding 
abilities. The in vitro cytotoxicity, cell uptake, and transfection efficiency of these PEI/DNA 
complexes were examined on the DC2.4 cell line. Finally, a maturation experiment evaluated 
the effect of costimulatory molecules CD40, CD80, and CD86 on murine bone marrow-derived 
DCs (BMDCs) using flow cytometry.
Results: PEI–TEG and man-PEI–TEG were successfully synthesized and were shown to retain 
the excellent properties of PEI25k for condensing DNA. Compared with PEI–TEG as well as 
PEI25k, the man-PEI–TEG had less cytotoxicity and performed better in both cellular uptake 
and transfection assays in vitro. The results of the maturation experiment showed that all the PEI/
DNA complexes induced an adequate upregulation of surface markers for DC maturation.
Conclusion: These results demonstrated that man-PEI–TEG can be employed as a DC-targeting 
gene-delivery system.
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Introduction
Over the last decade, there has been a lot of interest in DNA vaccines due to their   ability 
to achieve potent immune responses without the limitations of many   conventional 
vaccines. DNA vaccines offer a promising new approach for generating a wide range 
of desired immunities including cytolytic T lymphocytes (CTL), T helper cells, and 
antibodies, while being easy to manufacture, easy to administer, and safe.1 One of 
the keys to developing DNA vaccines is the establishment of an efficient and specific 
gene-delivery system that will allow the expression of antigen protein and subsequent 
activation of T-cell immunity.
A number of DNA delivery systems have been developed that utilize a variety 
of materials such as polymers, peptides, and cationic liposomes.2 Among these, the 
cationic polymer polyethyleneimine (PEI), which was introduced by Boussif et al3 has 
been widely studied due to its ability to deliver DNA with high efficiency. Because of 
its excellent performance as a vehicle for gene delivery, branched PEI25k has been used 
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as a standard reference for other new polymers. However, 
this system is significantly limited by its cytotoxicity.4 
Recent reports have demonstrated that, compared with low-
molecular-weight PEI (LMW-PEI, such as PEI2000), high-
molecular-weight PEI (HMW-PEI, such as PEI25k) exhibits 
higher transfection efficiency and higher cytotoxicity.5–7 In 
our previous study, a biodegradable LMW-PEI polymer 
(PEI–TEG) was synthesized by cross-linking LMW-PEI 
through biscarbamate linkages.8 It was shown that this was 
a promising and applicable gene-delivery carrier due to its 
lower cytotoxicity and higher gene transfection efficiency 
than commercial PEI25k.
Another major drawback of PEI-mediated gene-delivery 
systems is its nonspecific interaction with cells, which is 
especially important in DNA vaccine treatments that demand 
highly efficient delivery of antigen-encoded DNA to specific 
cells. A key point in the development of DNA vaccines is 
finding suitable target cells. Dendritic cells (DCs), which 
are the most effective antigen-presenting cells (APCs) of the 
immune system, are a key component for the regulation of both 
innate and adaptive immune responses as well as the mainte-
nance of immunological tolerance.9 Due to their unique ability 
to efficiently present antigens to T cells, many researchers have 
focused on their application in DNA vaccines in recent years, 
and there is tremendous potential in developing DNA vaccines 
that target DCs with a DNA delivery system.
To enhance the specificity of our delivery system to DCs, 
a specific ligand is required. It has been demonstrated that 
there is an abundant expression of mannose receptor (MR) 
on the surface of APCs, including DCs.10 The MR has been 
shown to select ligands carrying terminal sugars such as man-
nose and N-acetylglucosamine,11 and to transport these into 
cells through receptor-mediated endocytosis, which results in 
major histocompatibility complex (MHC) presentation and 
subsequent T cell activation.12,13 This suggests that the manno-
sylation of a drug- or gene-delivery system may improve their 
DC specificity and, as expected, some mannosylated proteins 
have been shown to enhance MHC-I and -II restricted antigen 
presentation as well as T cell stimulation compared with non-
mannosylated proteins.11,14 Furthermore, many mannosylated 
drug or gene-delivery systems such as mannosylated chitosan 
microspheres,15 mannosylated lipopolyplexes,16 mannosy-
lated PEI,17,18 mannosylated PEI-coupled mesoporous silica 
nanoparticles,19 and mannosylated chitosan-graft-PEI20 have 
been reported to augment transfection efficiency and immu-
nogenicity by targeting the MR on APCs. Therefore, in this 
study, mannose ligand was employed to provide selective DC 
targeting for the delivery of a DNA vaccine.
In the current study, a gene-delivery system based on 
a mannosylated, biodegradable LMW-PEI polymer (man-
PEI–TEG) was designed and synthesized for the purpose of 
improving DC specificity, increasing transfection efficiency, 
and reducing cytotoxicity. Physiochemical properties of the 
carrier and its complexes prepared with plasmid DNA were 
analyzed. The in vitro cytotoxicity, transfection efficiency, 
and DC maturation abilities were also investigated.
Materials and methods
Materials
Branched PEI 25k, branched PEI 2k, 3-(4,5-dimethyl-
thiazole-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), 
agarose, and HEPES were purchased from Sigma-Aldrich 
(St Louis, MO). PEI600 (Alfa Aesar, Ward Hill, MA) was 
used after vacuum drying at 70ºC for 1 hour. Triethyleneg-
lycol (TEG) was purchased from Kelong (Chengdu, China). 
The pGl4.10(luc2) (4242 bp) plasmid DNA was isolated and 
purified from DH5-α Escherichia coli using the Qiagen Giga 
Endo-free plasmid purification kit (Germantown, MD). Cell 
culture medium RPMI-1640 and fetal bovine serum (FBS) 
were obtained from Gibco Co (Life Technologies, Grand 
Island, NY). Luciferase assay system was procured from 
Promega (Madison, WI). BCA protein assay kit was obtained 
from KeyGEN. DC2.4 cell line was kindly provided by 
Dr Ying Wan of Third Military Medical University, China. 
All the other chemicals and solvents were obtained com-
mercially and used without further purification.
Synthesis and characterization of 
mannosylated PEI–TEg (man-PEI–TEg)
Synthesis of mannopyranosylphenyl isothiocyanate
Mannopyranosylphenyl isothiocyanate was synthesized 
according to the methods of Munch et al21 and Shi et al.22 
Briefly, 180 mL Ac2O and 210 mL C5H5N were added 
to a three-necked bottle and cooled to –5°C, after which 
20 g D-mannose was gradually added. The mixture was 
stirred for 5 hours at room temperature and then poured 
into 2 L of icy water. As a result, a crude acetylated man-
nose precipitate was obtained. BF3Et2O was added slowly 
to 11.7 g of the solution of the crude acetylated mannose 
precipitate and 8.4 g p-nitrophenol in 100 mL CH2Cl2. 
After this was stirred at 25°C for 24 hours, the solvent was 
removed and then purified by silica gel chromatography to 
yield p-nitrophenol-1-acetylated mannose. Then 5.5 g of 
the p-nitrophenol-1-acetylated mannose was dissolved in 
50 mL absolute MeOH and a small amount of MeONa was 
added and stirred at room temperature for 1 hour, then cation 
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exchange resin was added and this was stirred for another 
hour. After suction filtration, yellow filtrate (p-nitrophenol-
1-mannose) was obtained. After this, 10% Pd/C was added 
to the yellow filtrate and stirred at room temperature under 
H2 for 12 hours, after which the reaction mixture was filtered 
through celite. The solvent was removed by concentration in 
vacuo and then purified by silica gel chromatography to yield 
p-aminophenol-1-mannose. Following this, 1.56 mL CS2 and 
715 µL triethylamine were added to 700 µg of the solution of 
p-aminophenol-1-mannose in 1 mL EtOH. This was stirred 
for 30 minutes before being cooled to 0°C, and 4-dimeth-
ylaminopyridine (DAMP) followed by 950 µL Boc2O were 
then added to the cooled mixture. The reaction was stirred for 
another 20 minutes, after which the solvent was evaporated 
in vacuo and purified by silica gel chromatography to yield 
mannopyranosylphenyl isothiocyanate.
Synthesis of PEI polymer with triethyleneglycol 
(TEg) as the cross-linker (PEI–TEg)
The synthesis method of the PEI derivate with TEG as the cross-
linker was presented by Zhao et al.8 Briefly, 1.5 g anhydrous 
triethyleneglycol (TEG, 10.0 mmol) was dissolved in 250 mL 
anhydrous ethylene dichloride and then 6.04 g 4-nitrophenyl 
chloroformate (NPC, 30.0 mmol) was added. The solution 
was stirred and 4.15 mL EtN3 (30.0 mmol) was added. The 
reaction mixture was stirred at room temperature for 6 hours, 
and was subsequently washed with saturated NaCl solution 
and the organic phase was collected and dried over anhydrous 
Na2SO4. After this, the solvent was added dropwise to 20.0 g 
of the mixture of PEI600 and PEI2000, which was dissolved 
in ethylene dichloride, and the weight ratio of PEI600:PEI200 
(1:3) employed was optimized in a previous study (data not 
shown). After stirring for another 16 hours, the solution was 
evaporated to remove the solvent. The viscous residue was 
dissolved again in double-distilled water and dialyzed through 
a cellulose membrane with a molecular weight cut off of 3500 
for 5 days, and then, after 2 days of lyophilization, a solid or 
semisolid yellowish product or albicans product with a high 
viscosity was collected. This product was PEI–TEG.
Synthesis of man-PEI–TEg conjugates
The man-PEI–TEG conjugate had mannose linked to PEI via 
a phenylisothiocyanate bridge using mannopyranosylphenyl 
isothiocyanate as a coupling reagent, and was synthesized 
through a thiourea reaction according to the method of 
Diebold et al.18 Briefly, branched PEI–TEG was dissolved 
in distilled water and mixed with various amounts of 
mannopyranosylphenyl isothiocyanate in DMSO. The 
reaction was performed for 1 day at room temperature. 
Dialysis of the product against 150 mM NaCl for 2 days 
and then against double-distilled water for 3 days, followed 
by lyophilization, yielded the final product. The PEI–TEG 
to mannopyranosylphenyl isothiocyanate feed ratios of 1:1, 
2:1, and 3:1 were used in order to obtain three mannosylated 
derivates with different substitution degrees of mannose 
ligand. These derivates were named man-PEI–TEG-A, man-
PEI–TEG-B, and man-PEI–TEG-C, respectively (Table 1), 
or simply A, B, and C, respectively.
Characterization of man-PEI conjugates
Nuclear magnetic resonance (NMR) was used to confirm the 
structure of products. For proton NMR (1H-NMR) experi-
ments, the mannopyranosylphenyl isothiocyanate and PEI 
derivates were dissolved in CD3OD and D2O (purchased from 
Sigma-Aldrich) respectively. The samples were analyzed in 
a Varian UNITY INOVA 400 NMR Spectrometer (Varian 
Inc., Palo Alto, CA) at 400 MHz.
The molecular weight and polydispersity index (PDI) 
of the PEI–TEG and man-PEI–TEG conjugates were deter-
mined by gel permeation chromatography (GPC) relative to 
PEG standards (Polymer Labs, Amherst, MA).23
Compared to PEI–TEG, the molecular weights of man-
nosylated PEI–TEG A, B, and C were increasingly affected 
by an increase in mannose residues. The formula below can 
be used to calculate the weight ratio of mannose residues in 
man-PEI–TEG conjugates A, B, and C:
Mannose % = (Mw man-PEI–TEG - Mw PEI–TEG)/
  Mw man-PEI–TEG × 100%
Table 1 Characteristics of the PEI–TEg and man-PEI–TEg derivates: feed ratio, weight-average molecular weight (Mw), polydispersity 
index (PDI), and mannose content
Polymers PEI:mannose (weight ratio) Mw (kDa) PDI Theoretical mannose % Experimental mannose %
PEI–TEg 26.02 1.53
A 1:1 40.05 1.94 50.0% 35.0%
B 2:1 38.73 1.94 33.3% 32.8%
C 3:1 34.40 1.89 25.0% 24.4%
Abbreviations: PEI, polyethyleneimine; TEg, triethyleneglycol; PEI-TEg, polyethyleneimine and triethyleneglycol polymer; man-PEI-TEg, mannosylated PEI-TEg; A, man-
PEI-TEg derivative A; B, man-PEI-TEg derivative B; C, man-PEI-TEg derivative C; Mw, molecular weight; PDI, polydispersity index.
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man-PEI/DNA complex preparation
The preparation of the man-PEI–TEG/DNA complex was 
performed according to the delineation published by Kloeck-
ner et al.24 DNA plasmid (pGL4.10 (luc2)) was diluted in 5% 
glucose solution to a final concentration of 80 µg/mL, and 
the indicated amounts of man-PEI–TEG derivates were also 
diluted to the same volume with 5% glucose solution (pH 
4.0). Following this, the DNA solution was added into the 
PEI solution and was vortexed for 10 seconds, then incubated 
at room temperature for 20 minutes. To obtain complexes of 
different carrier: DNA ratios, DNA was condensed by man-
PEI–TEG derivatives at various mass ratios. In this work, 
PEI derivatives to DNA ratios were expressed by both weight 
ratios and N/P ratios, and the following formula can be used 
to convert the weight ratios to N/P ratios:25
N/P = (WPEI/WDNA) (EWDNA/EWPEI)
where N is the equivalent of ionizable nitrogen, P is the 
equivalent of ionizable phosphorous, W refers to weight, 
and EW refers to equivalent weight.
Particle size and zeta potential analysis
The mean particle size and zeta potential of the DNA/PEI 
complexes were determined at 25°C using photon correlation 
spectroscopy (PCS) (Zetasizer Nano ZS90; Malvern Instru-
ments Ltd, Worcestershire, UK). Before measurement, the 
PEI/DNA complexes of N/P ratios ranging from 5:1 to 40:1 
were prepared as described above. Each complex sample 
contained 10 µg plasmid DNA and was diluted to a final 
volume of 1 mL in 5% glucose solution.
gel retardation assays
Electrophoresis was employed to confirm the DNA bind-
ing ability of the man-PEI–TEG derivates. The PEI/DNA 
complexes were prepared at PEI:DNA mass ratios of 2:1 and 
3:1, then mixed with 6× loading buffer (Generay Biotech, 
Shanghai, China) and analyzed by gel electrophoresis on 
a 1.0% agarose gel containing 0.006% Goldview nucleic 
acid stain (Viswagen Biotech Pvt. Ltd, Kerala, India). After 
electrophoresis at 80 V for 45 minutes, the bands of plasmid 
DNA were visualized and photographed by molecular imager 
(ChemiDoc™ XRS system; Bio-Rad, Hercules, CA).
DNase I protection assay
The ability of man-PEI–TEG derivates to protect and release 
DNA in complex was ascertained by gel electrophoresis.26 
In short, 2 µL DNase I (1 unit) or phosphate-buffered saline 
(PBS; as a negative control) were added to 10 µL naked 
plasmid DNA solution (0.5 µg) or DNA/PEI complex 
solutions (with the mass ratio of PEI:DNA 3:1), and this 
was shaken at 100 rpm at 37°C for 1 hour. Following this, 
all of the samples were treated with 4 µL EDTA (250 mM) 
for 10 minute and then mixed with 10 µL sodium dodecyl 
sulfate (SDS) (1% in 0.1 M NaOH) for the purpose of DNase 
I inactivation and DNA release, respectively. The samples 
were incubated at room temperature for 1 hour, and then 
electrophoresis was performed under the same conditions 
described above.
Cytotoxicity assay
The cytotoxicity of man-PEI–TEG derivates was evaluated 
by 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium 
bromide (MTT) assay according to the method of Mosmann 
et al.27 The PEI/DNA complexes of each PEI derivate that was 
prepared at N/P ratios ranging from 5 to 50 were added to 
DC2.4 cells in 96-well plates. After incubation for 24 hours, 
MTT (5 mg/mL, 20 µL) was added and reacted for 4 hours at 
37°C. Following this, the medium of each well was replaced 
with 150 µL dimethylsulfoxide (DMSO) to dissolve the 
formazan crystals. The absorbance at 570 nm of each well 
was measured using a Varioskan® Flash multimode reader 
(Thermo Fisher Scientific, Waltham, MA). Cell viability 
was calculated by absorbance of cells pulsed with PEI, and 
absorbance of untreated cells × 100%. All values presented 
below represent means of multiple measurements with SD 
values indicated.
In vitro uptakes by DC2.4
Twenty-four hours prior to the experiments, DC2.4 cells 
were seeded in 6-wells plates in which each well had been 
covered by sterile coverslips at 4 × 105 cells/well. The 
fluorescence-labeled complexes were prepared by mixing 
fluorescein isothiocyanate (FITC)-labeled PEI derivates 
with DNA plasmid at the optimal N/P ratio of each derivate. 
After vortexing and incubating the complex solutions at 
room temperature for 20 minutes, these were added to the 
DC2.4 cells adhered to the coverslips in the 6-well plates. 
Cells were then incubated for 1 hour at 37°C; control cells 
were processed similarly but incubated at 4°C. Coverslips 
were then washed by dipping in PBS prior to fixation with 
4% paraformaldehyde (5 minutes, RT) and subsequent stain-
ing with 2 µg/mL diamidino phenylindole (DAPI). After 
washing the coverslips three times with PBS, they were 
then mounted on glass slides with 50% glycerol in 0.2 M 
Tris-HCl (pH 8.0) containing 2% n-propyl gallate to retard 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2932
Sun et alInternational Journal of Nanomedicine 2012:7
quenching of the fluorescence signal. Confocal microscopy 
was performed using a LSM510 confocal microscopy system 
(Carl Zeiss SMT GmBH, Heidelberg, Germany). All images 
were collected using the same values for photomultiplier 
gain, aperture diaphragm, and black levels.
In vitro competition assay
For competition assays, cells and fluorescence-labeled 
complexes were prepared as described above. To block the 
binding of man-PEI–TEG to MR, cells were pre-incubated 
for 20 minutes with 0.125 mg/mL mannan dissolved in 
RPMI-1640 or, as a control, with free RPMI-1640.   Following 
this, FITC labeled complexes were added and cells were 
incubated for 1 hour at 37°C. After washing the cells three 
times with PBS, these were removed from wells using 0.25% 
trypsin and resuspended in FACS buffer. The level of FITC 
fluorescence of cells was analyzed by flow cytometry using 
a FC500 flow cytometer (Beckman Coulter Inc, Brea, CA). 
Data analysis was performed using the Kaluza® software 
(Beckman Coulter Inc).
In vitro DC2.4 transfection assay
The transfection assay was performed on the DC2.4 cell 
line with the pGL4.10 (luc2) plasmid encoding luciferase 
as the reporter gene. DC2.4 cells cultured in RPMI-1640 
and supplemented with 10% FBS were seeded onto 24-well 
plates at 1 × 105 cells/well 24 hours before transfection. 
When approximately 70% confluence was reached, the cells 
were gently washed twice with PBS and the medium of each 
well was replaced with 200 µL serum-free culture medium. 
  Following this, 25 µL DNA/PEI complex solutions containing 
1 µg plasmid DNA at different N/P ratios was added to each 
well. After 4 hours of incubation, the transfection medium 
was removed and 1 mL fresh complete culture medium 
was added to each well and left to continue culturing for a 
further 20 hours at 37°C in a 5% CO2 incubator. Luciferase 
expression was measured using a luciferase assay system 
(Promega Corporation, Madison, WI) following the 
manufacturer’s instructions. The total protein concentration 
of transfected cells was determined by a BCA protein assay 
(KeyGEN,   Nanjing, China). The luciferase expression 
level was calculated as relative lights units (RLU)/mg total 
protein.
In vitro BMDCs maturation assay
BMDCs culture
Murine bone marrow-derived DCs (BMDCs) used in this 
experiment were derived as described by Inaba et al.28 The 
bone marrow progenitor cells were harvested from 6-week-old 
C57BL/6 male mice that were purchased from West China 
Experimental Animal Center of Sichuan University (China). 
Ten mice were sacrificed and sterilized with 75% ethanol. 
Femurs were gently removed from mice and the muscles 
adhered on bones were removed with sterilized gauze. The 
bones were then immersed in 75% ethanol for 2 minutes for 
sterilization, then washed twice with ice-cold PBS (pH 7.2), 
and cultured in a petri dish containing ice-cold RPMI-
1640 medium. Both ends (epiphyses) of each bone were 
cut off and each hollow of the bones was flushed with 2 mL 
RPMI-1640 medium by inserting a needle into the hollow 
to obtain as many cells as possible. The cell suspension was 
filtered through a 70 µm cell strainer (BD, Franklin Lakes, NJ) 
to remove tissue before centrifugation at 1000 rpm for 10 min-
utes to collect cells. These were then washed with RPMI-1640 
containing 10% FBS (1640-10F) and cultured in petri dishes 
with R5 medium (RPMI-1640 medium supplemented with 
20 ng/mL GM-CSF (R&D Systems,   Minneapolis, MN), 
10 mM HEPES, 50 µM 2-mercaptoethanol, 10% FBS, and 
antibiotic) at a total volume of 10 mL medium per dish. Cells 
were then washed and fed every 2 days. On day 4, aggregates 
of growing DC were observed attaching to the adherent 
stroma. These aggregates raised above the monolayer, in 
contrast to the flattened dispersed macrophage colonies. 
Spiky processes (dendrites) were also seen extending from the 
periphery of the aggregates, giving them a hairy or thistle-like 
appearance. On day 6, the aggregates were harvested by gently 
pipetting over the adherent stroma. The cells were pooled 
and centrifuged before being resuspended with RPMI-1640 
containing 50% FBS (1640-50F), and incubated at 37°C for 
30 minutes to dissociate the residual granulocytes. Following 
this, the cells were washed twice with 1640-10F medium and 
resuspended with R5 medium. They were then seeded into 
6-well plate at a cell density of 5 × 106 cells/well and a total 
volume of 2 mL/well.
To determine the purity of BMDCs (the percentage of 
CD11c+ cells), the FITC-labeled mouse CD11c antibody 
(eBiosience, San Diego, CA) was used to stain cells, which 
were then analyzed by flow cytometry. The percentage of 
CD11c+ cells in cultures was approximately 80%–90%.
BMDCs maturation in vitro
The DNA/PEI complexes were prepared with their optimal 
N/P ratios determined in the in vitro transfection experiment, 
and were added to BMDCs 6-well plates at 4 µg DNA per 
well. PBS and 2 µg/mL lipopolysaccharide (LPS) were also 
added as the negative and positive control, respectively. After 
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24 hours’ incubation, cells were washed and stained with 
PE-Cy5/FITC/PE-labeled mouse CD80/CD86/CD40 antibody 
(  eBiosience) at 4°C for 1 hour, then cells were determined by 
flow cytometry. The isotype control antibodies (eBiosience) 
for each type of the specific monoclonal antibody were 
employed to eliminate the autofluorescence of samples.
Results
Synthesis and characterization  
of man-PEI–TEg
The low molecular weight PEI polymers (PEI–TEG) and 
mannosylated PEI–TEG (man-PEI–TEG) were synthesized 
successfully. Figure 1 shows a simplified flowchart illus-
trating the method of synthesis. The composition of the 
synthesized copolymers was analyzed by 1H-NMR, and the 
chemical shift of each proton peak is showed in Figure 2. 
The proton peak of the phenylisothiocyanate in mannopy-
ranosylphenyl isothiocyanate (–CH–) appeared at 7.4–7.0 
ppm, and the proton peaks of PEI (–NHCH2CH2-) appeared 
at 3.3–2.5 ppm, confirming that mannose had successfully 
been linked to PEI–TEG.
Gel permeation chromatography (GPC) analysis 
determined that the average molecular weights (Mw) of 
PEI–TEG and three mannosylated derivates (A, B, and C) 
were 26.02, 40.05, 38.73, and 34.40 kDa, respectively. The 
weight ratios of mannose residues in man-PEI–TEG (A, B, 
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Figure 1 Synthetic route of mannosylated biodegradable PEI derivates. (A) mannopyranosylphenyl isothiocyanate; (B) PEI–TEg and man-PEI–TEg.
Abbreviations: Ac2O, acetic anhydride; C5H5N, pyridine; BF3Et2O, boron fluoride ethyl ether; Pd-C, palladium-carbon; TEA, triethylamine; Boc2O, di-tert-butyl dicarbonate; 
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and C) were calculated to be 35.0%, 32.8%, and 24.4%, 
respectively, which were consistent with the theoretical 
values (Table 1).
Characterization of PEI/DNA complex
A series of PEI/DNA complexes were successful obtained, 
and their pH ranged from 4.3 to 5.2 in 5% glucose solution. 
The DNA conveyance ability of PEI–TEG and man-PEI–
TEG was evaluated by examining properties such as zeta 
potential, particle size, and their ability to bind and protect 
DNA from DNase degradation.
The results of the average size and zeta-potential assays are 
shown in Figure 3, and it can be seen that the average particle 
size of all the complex samples spanned a range from 110 to 
260 nm, with a narrow size distribution (PDI , 0.2). Moreover, 
all of the DNA/PEI complexes (except those of derivates A and 
B at the N/P ratio of 5) were positively charged, with the positive 
charge increasing as the N/P ratio increased from 5 to 40.
The binding and condensation capability of the PEI 
derivates with DNA plasmid was evaluated using agarose 
gel electrophoresis. As shown in Figure 4A, when the mass 
ratio of PEI:DNA was 2:1, PEI25k, PEI–TEG, and man-
PEI–TEG-C could retard DNA completely, while man-PEI–
TEG-A and man-PEI–TEG-B could not retard all of the DNA 
plasmid. However, when the mass ratio increased to 3:1, no 
DNA band was seen, which indicates that all of the samples 
can retard DNA.
Figure 4B shows the result of DNase I protection. After 
being treated with DNase I for 1 hour at 37°C, mannosylated 
derivates A, B, and C, as well as PEI 25k and PEI–TEG, were 
able to protect DNA from enzymatic degradation at the mass 
ratio of 3:1. This is in contrast to naked plasmid DNA.
In vitro cytotoxicity, cellular uptake,  
and transfection on DC2.4
DC2.4, a dendritic cell line that expresses moderate MRs,10,29 
was used to determine the cytotoxicity, cellular uptake, and 
transfection efficiency of the PEI derivates/DNA complexes 
in vitro.
As is shown in Figure 5, cytotoxicity increased for all PEI/
DNA complexes as the N/P ratio increased, and the viability 
of cells treated by the three mannosylated derivates (A, B, 
and C) as well as PEI–TEG was significantly higher than that 
of commercial PEI25k. As well as this, when the N/P ratio 
was greater than 30 the relative cell viabilities of PEI–TEG 
began to decrease quickly, while those of the mannosylated 
derivates (A, B, and C) remained above 80% even at the 
highest N/P ratio of 50.
The expression of reporter genes was evaluated 
using a luciferase assay system, and the data shown 
7 654321 ppm
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Figure 2 1H-NMR spectrum of mannopyranosylphenyl isothiocyanate in CD3OD: δ = 7.1–7.2 (4Ar-H), δ = 5.5 (C1-H), δ = 3.2–4.0 (C2-H,C3-H,C4-H,C5-H.2C6-H); 
1H-NMR spectrum of PEI–TEg in D2O: δ = 4.23 (NHCOOCH2CH2OCH2), δ = 3.77 (NHCOOCH2CH2OCH2), δ = 3.73 (NHCOOCH2CH2OCH2), δ = 3.48; 
1H-NMR spectrum of PEI–TEg-A in D2O: δ = 4.23 (NHCOOCH2CH2OCH2), δ = 3.77 (NHCOOCH2CH2OCH2), δ = 3.73 (NHCOOCH2CH2OCH2), δ = 3.48 
(HOCH2CH2OCH2), δ = 3.3–2.5 (–NHCH2CH2–), δ = 7.0–7.4 (–CH–, mannopyranosylphenyl isothiocyanate).
Abbreviations: PEI, polyethyleneimine; TEg, triethyleneglycol; PEI-TEg, polyethyleneimine and triethyleneglycol polymer; PEI-TEg-A, mannosylated PEI-TEg derivative A; 
ppm, parts per million.
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in Figure 6 indicate that the luciferase expression in 
cells transfected with the positive control PEI25k/DNA 
complex was about 100 times greater than the expression 
of the naked plasmid DNA-treated group (P , 0.01), but 
remained 2–3 times lower than that of the PEI–TEG/DNA 
complex (P , 0.03). In contrast to this, the man-PEI–TEG/
DNA complexes exhibited an approximately three-times 
higher transfection efficiency than the complexes made 
from the PEI–TEG (P , 0.01). Among the three manno-
sylated PEI–TEG derivates, B (with the mannose weight 
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Figure 3 Characterization of PEI/DNA complex (n = 3). (A) Average particle size, (B) Zeta-potential.
Note: The PEI/DNA complexes were prepared at an N/P ratio ranging from 5:1 to 40:1, determined using photon correlation spectroscopy.
Abbreviations: PEI, polyethyleneimine; TEg, triethyleneglycol; PEI-TEg, polyethyleneimine and triethyleneglycol polymer; A, mannosylated PEI-TEg derivative A; B, 
mannosylated PEI-TEg derivative B; C, mannosylated PEI-TEg derivative C; PEI25k, polyethyleneimine with a molecular weight of 25 kD.
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Figure 4 DNA retardation and DNase I protection assay. (A) DNA-binding abilities of all PEI derivates were examined by agarose gel electrophoresis, and the examining 
mass ratios of PEI:DNA were 2:1 and 3:1 respectively. (B) PEI/DNA complexes were prepared at a ratio of 3:1 (w/w) and tested for their abilities to protecting DNA against 
the DNase I degradation.
Notes: +, samples treated with DNase I; –, samples treated with PBS.
Abbreviations: PEI, polyethyleneimine; TEg, triethyleneglycol; PEI-TEg, polyethyleneimine and triethyleneglycol polymer; A, mannosylated PEI-TEg derivative A; B, 
mannosylated PEI-TEg derivative B; C, mannosylated PEI-TEg derivative C; PEI25k, polyethyleneimine with a molecular weight of 25 kD.
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ratio of 32.8%) appeared to result in the highest transfection 
efficiency (P , 0.03).
The introduction of mannose as a ligand into the 
gene carriers for specific recognition by DC cells may 
enhance the transfer across the cell membrane, so the 
cellular uptake of complexes was also determined. Cells 
were incubated with FITC-labeled PEI derivates/DNA 
complexes at 37°C/4°C for 1 hour and then photographed 
by confocal microscopy. As is shown in Figure 7, after 
being incubated at 37°C for 1 hour the cells treated 
with man-PEI–TEG-B exhibited significantly more 
green fluorescence than those treated with PEI25k and 
PEI–TEG. For man-PEI–TEG-B, almost all of the green 
fluorescence was observed within the cells. In contrast, 
for PEI25k and, to an even greater extent, PEI–TEG, a 
large proportion of the green fluorescence did not enter 
the cell but only adsorbed onto the surface of the cells, 
so most of the green fluorescence was observed in rings 
around the cells. The uptake results of the three groups at 
4°C were approximately the same, indicating that almost 
no complex was taken up by cells.
In order to further investigate the mechanism of internal-
ization of mannosylated complexes, a competition experi-
ment was performed with mannan. As is shown in Figure 8, 
the mean fluorescence intensity (MFI) of man-PEI–TEG cells 
pre-incubated with mannan was 4–5-fold lower than that of 
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Figure 5 Cytotoxicity tests of the PEI/DNA complexes on the DC2.4 cell line.
Notes: The viability of cells treated with PEI/DNA complexes at various N/P ratios was measured by the MTT assay, and cells treated with culture media only were taken 
to be 100% viable. The data were represented as mean ± standard deviation (SD) of three independent experiments (n = 3).
Abbreviations:  PEI,  polyethyleneimine;  TEg,  triethyleneglycol;  PEI-TEg,  polyethyleneimine  and  triethyleneglycol  polymer;  A,  mannosylated  PEI-TEg  derivative 
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Figure 6 The transfection efficiency of PEI derivates/DNA complexes on the DC2.4 cell line in the absence of serum. The N/P ratios of complexes were optimized by a 
preliminary experiment, and the optimal N/P ratio of complex of PEI25k, PEI–TEg, and man-PEI–TEg conjugates A, B, and C were 10, 30, 50, 40, and 30, respectively. The 
data were represented as mean ± standard deviation (SD) of three independent experiments (n = 3).
Notes: P , 0.03 vs the group of PEI25k at its optimal N/P ratio; P , 0.001 vs the group of PEI25k and PEI–TEg at their optimal N/P ratio; P , 0.03 vs the group of 
man-PEI–TEg conjugates A and C at their optimal N/P ratio.
Abbreviations: PEI, polyethyleneimine; TEg, triethyleneglycol; PEI-TEg, polyethyleneimine and triethyleneglycol polymer; A, mannosylated PEI-TEg derivative A; B, 
mannosylated PEI-TEg derivative B; C, mannosylated PEI-TEg derivative C; PEI25k, polyethyleneimine with a molecular weight of 25 kD; DC, dendritic cells; RLU, relative 
light unit; SD, standard deviation.
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control cells. For PEI25k and PEI–TEG, the MFI of the two 
groups of cells were very similar.
BMDCs maturation in vitro
To assess the effect of PEI/DNA complexes on the 
maturation of mouse BMDCs, levels of the costimulatory 
molecules CD40, CD80, and CD86 were measured by 
flow cytometry. As is shown in Figure 9, after 24 hours of 
culturing with BMDCs, the positive control LPS conspicu-
ously upregulated the expression of the three costimulatory 
molecules, while PEI25k, PEI–TEG, and man-PEI–TEG 
all induced remarkable upregulation of the molecules com-
pared to the negative control (P , 0.01), but this was not 
as strong as that of LPS (P , 0.01), and the upregulation 
man-PEI–TEG-B PEI–TEG PEI25k
37°C
4°C
20 µm
20 µm 20 µm 20 µm
20 µm 20 µm
Figure 7 Confocal micrographs of cellular uptake of complexes on the DC2.4 cell line.
Notes: Cells were incubated with complexes prepared from PEI25k, PEI–TEg, and man-PEI–TEg-B, respectively, at 37°C/4°C for 1 hour prior to fixation with 4% 
paraformaldehyde (5 minutes, RT) and staining with 2 µg/mL diamidino phenyl indole (DAPI). Green fluorescence, FITC; blue fluorescence, DAPI.
Abbreviations: PEI, polyethyleneimine; TEg, triethyleneglycol; PEI-TEg, polyethyleneimine and triethyleneglycol polymer; man-PEI-TEg-B, mannosylated  PEI-TEg derivative 
B; PEI25k, polyethyleneimine with a molecular weight of 25 kD; DC, dendritic cells; RT, room temperature; DAPI, diamidino phenyl indole; FITC, fluorescein Isothiocyanate.
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Figure 8 Competition assay with mannan. Prior to the incubation with FITC labeled complexes, cells were pre-incubated with 0.125 mg/mg mannan for 20 minutes or as 
control with free medium. (A) A representative set of flow cytometry histograms. (B) The mean fluorescence intensity (MFI) of each group of cells.
Notes: P , 0.01, vs its control group; P . 0.05, vs its control group.
Abbreviations: PEI, polyethyleneimine; TEg, triethyleneglycol; PEI-TEg, polyethyleneimine and triethyleneglycol polymer; man-PEI-TEg, mannosylated PEI-TEg; PEI25k, 
polyethyleneimine with a molecular weight of 25 kD.
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intensity of the three carriers were approximately the same 
(P . 0.05).
Discussion
In the present study, a series of mannosylated biodegrad-
able LMW-PEI polymers (man-PEI–TEG) were designed 
and synthesized. The LMW-PEI polymer (PEI–TEG) was 
synthesized with triethyleneglycol (TEG) as the cross-linker 
and, to be assigned the DC specificity, the PEI–TEG was man-
nosylated by the thiourea reaction between the   isothiocyanate 
group of mannopyranosylphenyl   isothiocyanate and the 
primary amine groups of PEI–TEG. Three man-PEI–TEG 
conjugates (A, B, and C) were obtained, for which the man-
nose substitution degrees were 35%, 32.8%, and 24.4%, 
respectively. It appears that this is the first time that this kind 
of PEI derivate has been reported.
To ensure that the PEI–TEG and its mannosylated deri-
vates that were generated are capable of delivering plasmid 
DNA, they must be able to bind and condense the plasmid 
DNA as efficiently as PEI alone. The results of gel electro-
phoresis to ascertain derivates’ DNA condensation ability 
suggest that the DNA binding abilities of PEI25k, PEI–TEG, 
and C were stronger than those of A and B (Figure 4), which 
may be ascribed to the less positive charge that A and B have 
due to the mannosylation of the primary amines. This sug-
gests that a higher weight ratio of A/B to DNA is required to 
completely condense plasmid DNA, while DNA in the gene 
vehicle should be protected from enzymatic degradation for 
efficient transfection. The electrophoresis assay also indicated 
that PEI–TEG and its mannosylated derivates A, B, and C 
were all able to protect DNA against hydrolysis by nucleases. 
Furthermore, according to the results of photon correlation 
spectroscopy, the particle sizes of all PEI/DNA complexes 
made by these derivates were nano-sized (110–260 nm) 
with a narrow distribution, which would be favorable for 
gene delivery. These results indicate that the man-PEI–TEG 
derivates have retained the excellent properties of PEI for a 
self-assembled nanoparticle system.
Applicable gene carriers should be non-toxic or mini-
mally toxic, so it was necessary to measure the cytotoxicity 
of the PEI derivates using a MTT assay. The results (Figure 5) 
indicate that the cytotoxicity of complexes prepared by 
PEI–TEG was significantly lower than that of commercial 
PEI25k, which was consistent with previous studies.8 When 
the N/P ratio increased to 30, however, the cytotoxicity of the 
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Figure 9 Expression of maturation surface markers (CD40, CD80, and CD86) in BMDCs treated with PEI/DNA complexes. PEI/DNA complexes were prepared at their 
optimal N/P ratio, and cells treated with PBS and LPS were used as the negative and positive controls, respectively. (A) A representative set of flow cytometry histograms. 
Black line: cells treated with PBS. (B) Normalized expression level of maturation markers. The data were represented as mean ± standard deviation (SD) of three independent 
experiments (n = 3).
Notes: P , 0.01, vs the group of PBS and LPS; P . 0.05, vs the group of PEI25k and PEI–TEg.
Abbreviations:  PEI,  polyethyleneimine;  TEg,  triethyleneglycol;  PEI-TEg,  polyethyleneimine  and  triethyleneglycol  polymer;  man-PEI-TEg-B,  mannosylated    PEI-TEg 
derivative B; PEI25k, polyethyleneimine with a molecular weight of 25 kD; DC, dendritic cells; BMDC, Murine bone marrow-derived DCs; LPS, lipopolysaccharide; SD, 
standard deviation.
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PEI–TEG/DNA complexes remained low. This indicates that 
the incorporation of mannose residues played a further role 
in diminishing the toxicity of carriers.
In the preliminary transfection experiment it was initially 
found that the transfection efficiency of PEI derivates would 
be enhanced as the N/P ratio of the PEI/DNA complex was 
increased. When the N/P ratio was increased too much, 
however, the transfection efficiency began to drop due to the 
increasing cytotoxicity of the complexes. As the cytotoxicity 
of the carriers differed, the optimal transfection N/P ratio for 
each polymer was selected to ensure that all carriers could 
obtain an optimal transfection efficiency (data not shown). 
In the DC2.4 cell line, the optimal N/P ratios of the complex 
of PEI25k, PEI–TEG, and man-PEI–TEG conjugates A, B, 
and C were 10, 30, 50, 40, and 30, respectively. Based on the 
MTT assay, the relative cell viabilities of complexes were all 
above 80% at their optimal N/P ratio. It was demonstrated 
in the transfection result (Figure 6) that the biodegradable 
LMW-PEI polymer PEI–TEG had a better performance 
in transfection than commercial PEI25k. The most likely 
reason for this is that the degradable PEI–TEG polymer had 
a capacity for binding to negatively charged molecules (such 
as translation-related proteins or mRNA) in the cytoplasm, 
which would inhibit transfection.8,30 Moreover, the mannose 
residues significantly improved the transfection efficiency of 
the carrier system. The degree of mannosylation, however, 
did not simply increase as more mannose was added. In a 
previous study mannosylated derivates were introduced with 
different PEI–TEG to mannopyranosylphenyl isothiocyanate 
feed ratios (1:4, 1:3, 1:2, 4:1, and 8:1), and these had an 
inferior performance to those in the current study (1:1, 
2:1, and 3:1) (data not shown). Moreover, among the three 
mannosylated derivates reported here, B (32.8% mannose) 
performed better than A (35% mannose) and C (24.4% 
mannose). As has been reported previously,3,5 the cationic 
polymer PEI has a strong buffering capacity due to the 
numerous primary amines in its structure, and this could 
protect DNA from nuclease degradation and facilitate 
endosomal escape through the “proton sponge hypothesis,” 
so becoming highly efficient at delivering DNA. In order 
to synthesize the man-PEI–TEG conjugate, mannose had 
to be linked to PEI via a phenylisothiocyanate bridge 
between the isothiocyanate group of mannopyranosylphenyl 
isothiocyanate and the primary amine groups of PEI, which 
meant that the more mannose residues that were linked the 
weaker buffering capacity the conjugates had. The result of 
this was that while the mannose residues could offer the carry 
system the potential to target the MRs expressed on DCs and 
thus enhance their uptake by receptor-mediated endocytosis, 
after uptake by cells these residues could slow the further 
function of PEI. This indicates that it is important to find a 
balance between those two factors; the current study suggests 
that man-PEI–TEG-B has optimal mannosylation.
The improved cellular trafficking of synthesized 
polymers was also confirmed by confocal microscopy. 
As shown in Figure 7, significantly more fluorescence 
had been internalized by cells treated with man-PEI–
TEG-B and localized in cytoplasm after 60 minutes’ 
incubation at 37°C than was observed in either PEI25k 
or PEI–TEG. Additionally, the complexes prepared with 
PEI–TEG were more likely to be located at the area close 
to the membrane, while most of the green fluorescence 
appeared  within the cells of the man-PEI-TEG-B-treated 
group. This indicates that, as expected, incorporation of 
mannose ligand can facilitate the cellular uptake of the 
complexes via an alternative pathway that was most likely 
receptor-mediated endocytosis. However, the correlation 
between the amount of uptake and the substitution degrees 
of mannose ligand was not significant in the current study 
(data not shown).
Furthermore, as was observed in the competition assay 
(Figure 8), the uptake of man-PEI–TEG/DNA complexes 
was significantly inhibited in the presence of mannan, while 
those of PEI25k/DNA and PEI–TEG/DNA were relatively 
unaffected. This confirmed our hypothesis that the internal-
ization of the mannosylated complexes predominantly occurs 
via mechanisms dependent on MRs on the cell surface (that 
is, MR-mediated endocytosis).
It is well known that immature DCs (iDCs) are 
specialized for antigen capture whereas mature DCs are 
capable of antigen-presentation and T cell-priming, and the 
ability of DCs to regulate immunity is dependent on DC 
maturation stage. This means that when a gene-delivery 
system targeting DCs is designed, the DC maturation ability 
of the system is a crucial parameter to consider. A variety 
of factors can induce maturation following antigen uptake 
and processing within DCs, including whole bacteria 
or bacterial-derived antigens (eg, lipopolysaccharide), 
ligands of certain cell surface receptors (eg, CD40), 
inflammatory cytokines, and viral products (eg, double-
stranded RNA). During their conversion from immature 
to mature cells, DCs undergo a number of phenotypical 
and functional changes including a redistribution of major 
histocompatibility complex molecules from intracellular 
endocytic compartments to the DC surface, down-regulation 
of antigen internalization, and upregulation of the surface 
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expression of costimulatory molecules such as CD40, 
CD80, and CD86.31–35 With this in mind, the maturation 
stage of BMDCs through the expressing level of CD40, 
CD80, and CD86 were examined with PBS and LPS as 
negative and positive controls, respectively. The results, 
shown in Figure 9, show that the maturation abilities of 
complexes based on PEI derivates were not as strong as 
those of LPS. However, compared to other systems such as 
poly(lactic-co-glycolic acid) and polyethylene glycol-block-
poly(aminoethyl methacrylate),36,37 which had been reported 
to only slightly alter the phenotypes of iBMDCs, the PEI 
system in the current study could significantly upregulate 
the expression of the costimulatory molecules. Given that 
CD40 and CD86 play an important role in the induction 
of adaptive immunity through activation of CD4+ T cells, 
this result would be beneficial for the application of DNA 
vaccines specifically targeting DCs.33
Conclusion
In this study, a series of man-PEI–TEGs were successfully 
synthesized and evaluated as a novel gene delivery carrier for 
DC targeting. The man-PEI–TEG polymers demonstrated the 
ability to form PEI/DNA complexes with physicochemical 
properties that would make them suitable as a gene delivery 
carrier. Furthermore, man-PEI–TEG showed significantly 
lower cytotoxicity and higher transfection efficiency on 
the DC2.4 cell line than commercial PEI25k, and demon-
strated adequate maturation ability on BMDCs. With fur-
ther improvement, it appears that these mannosylated PEI 
polymers will show potential as carriers for targeting DNA 
vaccines to DCs.
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